Finance News World

Biomarkers Market Anticipated To Reach Over USD 129.4 Billion By 2027 : Grand View Research Inc.

 Breaking News
  • No posts were found

Biomarkers Market Anticipated To Reach Over USD 129.4 Billion By 2027 : Grand View Research Inc.

March 18
01:08 2020
Biomarkers Market Anticipated To Reach Over USD 129.4 Billion By 2027 : Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global biomarkers market size was valued at USD 46.3 billion in 2019 and is expected to expand at a CAGR of 13.7% over the forecast period.

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027, according to a new study conducted by Grand View Research Inc. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, nonprofitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott; F. Hoffmann-La Roche Ltd.; Qiagen; Siemens Healthcare Private Limited; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Johnson & Johnson Services, Inc; Agilent Technologies, Inc.; and Epigenomics AG. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

U.S. biomarkers market size, by application, 2015 - 2027 (USD Billion)

Request a sample Copy of the Biomarkers Market Research Report @ https://www.grandviewresearch.com/industry-analysis/biomarkers-industry/request/rs1

Key Takeaways Of The Report :

  • Safety biomarkers captured more than 41% market share in 2019, driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition

  • Validation biomarkers is expected to demonstrate the fastest CAGR through to 2027

  • Personalized medicine is likely to expand at a CAGR of 14.8% over the forecast period due to consumer awareness and preferences

  • Cancer dominated the disease segment in 2019, driven by a high disease burden and presence of a strong pipeline

  • Cardiovascular disease segment is projected to witness the fastest growth in the forthcoming years, supported by the growing obese population base and sedentary lifestyles

Germany biomarkers market share, by disease, 2019 (%)

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/70/ibb

Grand View Research has segmented the global biomarkers market on the basis of type, application, disease, and region:

Biomarkers Type Outlook (Revenue, USD Million, 2015 – 2027)

  • Safety

  • Efficacy

  • Validation

Biomarkers Application Outlook (Revenue, USD Million, 2015 – 2027)

  • Diagnostics

  • Drug Discovery & Development

  • Personalized Medicine

  • Others

Biomarkers Disease Outlook (Revenue, USD Million, 2015 – 2027)

  • Cancer

  • Cardiovascular Disease

  • Neurological Disease

  • Immunological Disease

  • Others

Biomarkers Regional Outlook (Revenue, USD Million, 2015 – 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • France

    • Italy

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

Browse Related Report:

Neurological Biomarkers Market : https://www.grandviewresearch.com/industry-analysis/neurological-biomarkers-market

Anatomic Pathology Market : https://www.grandviewresearch.com/industry-analysis/anatomic-pathology-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/biomarkers-industry